EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA
CenterBook Partners LP Grows Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political
Analysts' Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)
Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Bold $499 Fair Value Narrative
Recent Analysts' Ratings Updates for BioNTech (BNTX) - Daily Political
How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO
BNTX: Leadership Upheaval And Oncology Trial Risks Will Pressure Expectations
BioNTech (NASDAQ:BNTX) Earns Buy Rating from Jefferies Financial Group
BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from Jefferies Financial Group - Stock Observer
Monaco Asset Management SAM Takes Position in BioNTech SE Sponsored ADR $BNTX
BMY: Promising Phase 2 Results for Pumitamig in Lung Cancer Treatment
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?
BNP Paribas Financial Markets Raises Stock Holdings in BioNTech SE Sponsored ADR $BNTX
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial | Valuespectrum.com
BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap
BNTX Upgraded by UBS -- Price Target Raised to $135
BioNTech (BNTX) Valuation Check After New Late Stage Oncology Data At 2026 ASCO Meeting
BioNTech (NASDAQ:BNTX) Upgraded at Sanford C. Bernstein - Daily Political
Bernstein starts BioNTech at Market Perform, sees high registration risk
Leonteq Securities AG Invests $2.61 Million in BioNTech SE Sponsored ADR $BNTX
Did Adding Oncology Veterans to the Supervisory Board Just Shift BioNTech's (BNTX) Investment Narrative? - Simply Wall St News
Assessing BioNTech (BNTX) Valuation After Prolonged Share Price Weakness And Loss Making Results
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
Biontech SE Annual Shareholders Meeting Transcript
BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM
BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center
CDC admits Moderna vaccine poses higher risk of heart inflammation
Berenberg Bank Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00
BioNTech (BNTX) Sees Price Target Adjustment Amid Oncology Pipeline Valuation
Why BioNTech (BNTX) Is Down 5.3% After Authorizing a $1 Billion ADS Buyback and Reaffirming 2026 Guidance
BioNTech: Profit takes precedence over health-and 1,860 employees lose their jobs in Germany - World Socialist Web Site
BioNTech News
US Stock Market Correction: Banks Warn of Lingering Risks Amidst Shifting Momentum
Bond Market Re-evaluation Amid Geopolitical Shifts and Inflationary Pressures
SpaceX IPO Momentum Builds: MSCI Inclusion Expected to Drive Significant Inflows
Intel Foundry Poised for Major Gains with Potential Google and Nvidia Partnerships
CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts
Latest news
Show moreEconomic Volatility, Inflation Fears, and AI-Driven Stock Market Dynamics
India's Gold Smuggling Surges Post Tariff Hike, Shadow Market Dominates
Pakistan: US-Iran Peace Deal Unlikely Soon Amid Israeli Ceasefire Violations
Hormuz Strait Disruption: Market Expectations, Geopolitical Triggers, and the Oil Price Paradox
Bank of Japan May Halt Bond Purchases After 2027, Signaling Pivot on Quantitative Tightening
AI IPO Race Intensifies: OpenAI and Anthropic File Confidentially, SpaceX Gears Up for Market
